Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: A potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents

Translational Research

Volumn 161, Issue 3, 2013, Pages 156-164

  Duan, Wenrui ^a,b   Gao, Li ^a   Zhao, Weiqiang ^a   Leon, Marino ^a   Sadee, Wolfgang ^a   Webb, Amy ^a   Resnick, Kimberly ^a   Wu, Xin ^a   Ramaswamy, Bhuvaneswari ^a,b   Cohn, David E ^a   Shapiro, Charles ^a,b   Andreassen, Paul R ^c   Otterson, Gregory A ^a,b   Villalona Calero, Miguel A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; FANCONI ANEMIA GROUP D2 PROTEIN; FORMALDEHYDE; MONOCLONAL ANTIBODY KI 67; PARAFFIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; UBIQUITINATION; WESTERN BLOTTING;

EID: 84873888067     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.09.003     Document Type: Article

References (32)

1. H.E. Bryant, N. Schultz, and H.D. Thomas Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913 917
2. H. Farmer, N. McCabe, and C.J. Lord Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 2005 917 921
3. A. Tutt, M. Robson, and J. Garber Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial Lancet 376 2010 235 244
4. M.W. Audeh, J. Carmichael, and R.T. Penson Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial Lancet 376 2010 245 251
5. P. Fong, D. Boss, and T. Yap Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N Engl J Med 361 2009 23 34
6. G.C. Bagby Jr. Genetic basis of Fanconi anemia Curr Opin Hematol 10 2003 68 76
7. A.D. D'Andrea, and M. Grompe The Fanconi anaemia/BRCA pathway Nat Rev Cancer 3 2003 23 34
8. A.D. Auerbach, and R.G. Allen Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry Cancer Genet Cytogenet 51 1991 1 12
9. S. Reid, D. Schindler, and H. Hanenberg Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer Nat Genet 39 2007 162 164
10. B. Xia, J.C. Dorsman, and N. Ameziane Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Nat Genet 39 2007 159 161
11. B. Xia, Q. Sheng, and K. Nakanishi Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 22 2006 719 729
12. A. Smogorzewska, S. Matsuoka, and P. Vinciguerra Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair Cell 129 2007 289 301
13. K.N. Yamamoto, S. Kobayashi, and M. Tsuda Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway Proc Natl Acad Sci U S A 108 2011 6492 6496
14. Y. Kim, F.P. Lach, R. Desetty, H. Hanenberg, A.D. Auerbach, and A. Smogorzewska Mutations of the SLX4 gene in Fanconi anemia Nat Genet 43 2011 142 146
15. C. Stoepker, K. Hain, and B. Schuster SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype Nat Genet 43 2011 138 141
16. F. Vaz, H. Hanenberg, and B. Schuster Mutation of the RAD51C gene in a Fanconi anemia-like disorder Nat Genet 42 2010 406 409
17. K. Somyajit, S. Subramanya, and G. Nagaraju RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer Carcinogenesis 31 2010 2031 2038
18. Y.J. Machida, Y. Machida, and Y. Chen UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation Mol Cell 23 2006 589 596
19. A.R. Meetei, Z. Yan, and W. Wang FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination Cell Cycle 3 2004 179 181
20. A.R. Meetei, J.P. de Winter, and A.L. Medhurst A novel ubiquitin ligase is deficient in Fanconi anemia Nat Genet 35 2003 165 170
21. S.M. Nijman, T.T. Huang, and A.M. Dirac The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway Mol Cell 17 2005 331 339
22. I. Garcia-Higuera, T. Taniguchi, and S. Ganesan Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway Mol Cell 7 2001 249 262
23. A.A. Clarke, F.M. Gibson, J. Scott, N. Myatt, and T.R. Rutherford Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies Haematologica 89 2004 11 20
24. Y. Wang, T. Wiltshire, J. Senft, S.L. Wenger, E. Reed, and W. Wang Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven Mol Cancer Ther 5 2006 3153 3161
25. A. Lyakhovich, and J. Surralles Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer Cancer Lett 232 2006 99 106
26. K. Neveling, R. Kalb, and A.R. Florl Disruption of the FA/BRCA pathway in bladder cancer Cytogenet Genome Res 118 2007 166 176
27. M. Tischkowitz, B. Xia, and N. Sabbaghian Analysis of PALB2/FANCN-associated breast cancer families Proc Natl Acad Sci U S A 104 2007 6788 6793
28. T. Taniguchi, M. Tischkowitz, and N. Ameziane Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 2003 568 574
29. N. McCabe, N.C. Turner, and C.J. Lord Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition Cancer Res 66 2006 8109 8115
30. H. Willers, A.G. Taghian, C.M. Luo, A. Treszezamsky, D.C. Sgroi, and S.N. Powell Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies Mol Cancer Res 7 2009 1304 1309
31. W. Duan, L. Gao, and X. Wu MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells Int J Cancer 172 2010 313 320
32. M. Tarsounas, D. Davis, and S. West BRCA2-dependent and independent formation of RAD51 nuclear foci Oncogene 22 2003 1115 1123